Company intelligence / Profile preview

12 Sigma Technologies

Shenzhen, China

Ownership: Private
Development stage: Other

Overview

12 Sigma Technologies has developed and commercialized AI-powered diagnostic software that uses deep learning to assist physicians in the accurate detection and segmentation of findings on medical images, with products deployed in various healthcare settings[3][4].

Therapeutic areas: NeurologyPulmonologyOtherOncology
Modalities: DeviceSoftware
Industry: Medical Imaging

Partnerships

Partnerships likely with hospitals and health systems for deployment and validation

Beyond the preview

Go deeper on 12 Sigma Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 12 Sigma Technologies.

Explore the full profile